Baird Medical Investment Holdings (BDMD) Cash & Equivalents (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has 3 years of Cash & Equivalents data on file, last reported at $387496.0 in Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 86.95% year-over-year to $387496.0 in Q4 2025; TTM through Dec 2025 was $387496.0, a 86.95% decrease from a year earlier, with the FY2025 full-year figure at $387496.0, down 86.95% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $387496.0, down from $2.2 million in the prior quarter.
• Over the last five years, Cash & Equivalents for BDMD reached as high as $3.0 million in Q4 2024 and fell as low as $387496.0 in Q4 2025.
• Historically, Cash & Equivalents has averaged $1.8 million across 3 years, with a median of $1.8 million in 2023.
• Across the five-year window, Cash & Equivalents surged 96.64% in 2024 and sank 86.95% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $1.5 million in 2023, then jumped by 96.64% to $3.0 million in 2024, then sank by 86.95% to $387496.0 in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $387496.0 in Q4 2025, $2.2 million in Q2 2025, and $3.0 million in Q4 2024.